Abstract
The human gut microbiota is critical for regulation of whole body metabolism and the immune system. Probiotics provide many benefits on human health by regulating this microbiota. In the prevention of infectious diseases, several probiotic Lactobacillus strains are shown to be effective to enhance the effects of influenza vaccine. These effects are mediated by increment of NK cell population, T-helper type 1 response, and production of virus-specific IgA, IgG, and IgM to inhibit the viral infection. Recently, we have shown that Lactobacillus gasseri LG2055 is effective to prevent influenza by induction of IFNβ production and expression of antiviral genes to inhibit the viral replication. In addition, the inflammatory response is inhibited, and cytokine production to stimulate B cells is induced by the administration of LG2055. Especially, IFNβ inhibits the replication of influenza virus and IFNβ production signal is mediated by IPS-1 through the activation of IRF3 and NF-κB. Therefore, in the future, the regulatory effects on the function or expression of these signaling molecules by the administration of probiotics should be studied. In addition, since the inhibition of FasL-induced apoptosis is effective to protect mice from death by the viral infection, the function of other death receptors, TNFR, DR4, and DR5, or signaling molecules, Siva-1, DAP3, and DELE, should be clarified in the viral replication and apoptosis induction. Further investigation for the regulatory effects of probiotics on the function of these molecules is required and might lead to the development of novel influenza drugs or vaccine adjuvants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101(44):15718–15723
Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27(41):5677–5684. doi:10.1016/j.vaccine.2009.06.094
Bosch M, Méndez M, Pérez M, Farran A, Fuentes MC, Cuñé J (2012) Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutr Hosp 27(2):504–509. doi:10.1590/S0212-16112012000200023
Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470–1481
Chan PK (2002) Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 34(Suppl 2):S58–S64
Chen Z, Li Y, Krug RM (1998) Chimeras containing influenza NS1 and HIV-1 Rev protein sequences: mechanism of their inhibition of nuclear export of Rev protein–RNA complexes. Virology 241:234–250
Corthésy B (2013) Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol 4:185
Davidson LE, Fiorino AM, Snydman DR, Hibberd PL (2011) Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr 65(4):501–507. doi:10.1038/ejcn.2010.289
Fujikura D, Chiba S, Muramatsu D, Kazumata M, Nakayama Y, Kawai T, Akira S, Kida H, Miyazaki T (2013) Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza. PLoS One 8(2), e55321. doi:10.1371/journal.pone.0055321
Fujioka Y, Tsuda M, Hattori T, Sasaki J, Sasaki T, Miyazaki T, Ohba Y (2011) The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses. PLoS One 6(1), e16324. doi:10.1371/journal.pone.0016324
Fujioka Y, Tsuda M, Nanbo A, Hattori T, Sasaki J, Sasaki T, Miyazaki T, Ohba Y (2013) A Ca(2+)-dependent signalling circuit regulates influenza A virus internalization and infection. Nat Commun 4:2763. doi:10.1038/ncomms3763
Fukada K, Fujikura D, Nakayama Y, Kondoh M, Shimada T, Miyazaki T (2013) Enterococcus faecalis FK-23 affects alveolar-capillary permeability to attenuate leukocyte influx in lung after influenza virus infection. Springerplus 2(1):269. doi:10.1186/2193-1801-2-269
Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S (2007) NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36(3):263–269
Gupta S (2001) Molecular steps of death receptor and mitochondrial pathways of apoptosis. Life Sci 69(25-26):2957–2964
Hale BG, Randall RE, Ortin J, Jackson D (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89:2359–2376
Harada T, Iwai A, Miyazaki T (2010) Identification of DELE, a novel DAP3-binding protein which is crucial for death receptor-mediated apoptosis induction. Apoptosis 15(10):1247–1255. doi:10.1007/s10495-010-0519-3
Hinshaw VS, Olsen CW, Dybdahl-Sissoko N, Evans D (1994) Apoptosis: a mechanism of cell killing by influenza A and B viruses. J Virol 68:3667–3673
Iwai A, Shiozaki T, Kawai T, Akira S, Kawaoka Y, Takada A, Kida H, Miyazaki T (2010) Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. J Biol Chem 285(42):32064–32074. doi:10.1074/jbc.M110.112458
Iwai A, Shiozaki T, Miyazaki T (2013) Relevance of signaling molecules for apoptosis induction on influenza A virus replication. Biochem Biophys Res Commun 441(3):531–537. doi:10.1016/j.bbrc.2013.10.100
Jackson D, Killip MJ, Galloway CS, Russell RJ, Randall RE (2010) Loss of function of the influenza A virus NS1 protein promotes apoptosis but this is not due to a failure to activate phosphatidylinositol 3-kinase (PI3K). Virology 396:94–105
Kadooka Y, Tominari K, Sakai F, Yasui H (2012) Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055. J Pediatr Gastroenterol Nutr 55:66–71
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357(9262):1076–1079
Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6(10):981–988
Kechaou N, Chain F, Gratadoux JJ, Blugeon S, Bertho N, Chevalier C, Le Goffic R, Courau S, Molimard P, Chatel JM, Langella P, Bermúdez-Humarán LG (2013) Identification of one novel candidate probiotic Lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening. Appl Environ Microbiol 79(5):1491–1499. doi:10.1128/AEM.03075-12
Kikuchi Y, Kunitoh-Asari A, Hayakawa K, Imai S, Kasuya K, Abe K, Adachi Y, Fukudome S, Takahashi Y, Hachimura S (2014) Oral administration of Lactobacillus plantarum strain AYA enhances IgA secretion and provides survival protection against influenza virus infection in mice. PLoS One 9(1), e86416. doi:10.1371/journal.pone.0086416. eCollection 2014
Kim HR, Chae HJ, Thomas M, Miyazaki T, Monosov A, Monosov E, Krajewska M, Krajewski S, Reed JC (2007) Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis. FASEB J 21(1):188–196
Kiso M, Takano R, Sakabe S, Katsura H, Shinya K, Uraki R, Watanabe S, Saito H, Toba M, Kohda N, Kawaoka Y (2013) Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus. Sci Rep 3:1563. doi:10.1038/srep01563
Kleerebezem M, Vaughan EE (2009) Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 63:269–290. doi:10.1146/annurev.micro.091208.073341
Kondoh M, Fukada K, Fujikura D, Shimada T, Suzuki Y, Iwai A, Miyazaki T (2012) Effect of water-soluble fraction from lysozyme-treated Enterococcus faecalis FK-23 on mortality caused by influenza A virus in mice. Viral Immunol 25(1):86–90. doi:10.1089/vim.2011.0056
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023
Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, Zhang Y, Shen J, Pang X, Zhang M, Wei H, Chen Y, Lu H, Zuo J, Su M, Qiu Y, Jia W, Xiao C, Smith LM, Yang S, Holmes E, Tang H, Zhao G, Nicholson JK, Li L, Zhao L (2008) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 105:2117–2122
Li HM, Fujikura D, Harada T, Uehara J, Kawai T, Akira S, Reed JC, Iwai A, Miyazaki T (2009) IPS-1 is crucial for DAP3-mediated anoikis induction by caspase-8 activation. Cell Death Differ 16(12):1615–1621. doi:10.1038/cdd.2009.97
Maeda N, Nakamura R, Hirose Y, Murosaki S, Yamamoto Y, Kase T, Yoshikai Y (2009) Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol 9(9):1122–1125. doi:10.1016/j.intimp.2009.04.015
Matsuda M, Suizu F, Hirata N, Miyazaki T, Obuse C, Noguchi M (2010) Characterization of the interaction of influenza virus NS1 with Akt. Biochem Biophys Res Commun 395(3):312–317. doi:10.1016/j.bbrc.2010.03.166
Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620–625
Medina RA, García-Sastre A (2011) Influenza A viruses: new research developments. Nat Rev Microbiol 9(8):590–603. doi:10.1038/nrmicro2613
Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172
Mibayashi M, Martínez-Sobrido L, Loo YM, Cárdenas WB, Gale M Jr, García-Sastre A (2007) Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524
Miyazaki T, Reed JC (2001) A GTP-binding adapter protein couples TRAIL receptors to apoptosis-inducing proteins. Nat Immunol 2(6):493–500
Miyazaki T, Shen M, Fujikura D, Tosa N, Kim HR, Kon S, Uede T, Reed JC (2004) Functional role of death-associated protein 3 (DAP3) in anoikis. J Biol Chem 279(43):44667–44672
Nakayama Y, Moriya T, Sakai F, Ikeda N, Shiozaki T, Hosoya T, Nakagawa H, Miyazaki T (2014) Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci Rep 4:4638. doi:10.1038/srep04638
Neumann G, Brownlee GG, Fodor E, Kawaoka Y (2004) Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 283:121–143
Nicholson JK, Holmes E, Wilson ID (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol 3(5):431–438, Review
Olivares M, Díaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonollá J, Navas M, Rodríguez JM, Xaus J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23(3):254–260
Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T (2007) IFN beta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9(4):930–938
Pichlmair A, Schulz O, Tan CP, Näslund TI, Liljeström P, Weber F, Reis e Sousa C (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314:997–1001
Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16(4):658–672
Sakai F, Hosoya T, Ono-Ohmachi A, Ukibe K, Ogawa A, Moriya T, Kadooka Y, Shiozaki T, Nakagawa H, Nakayama Y, Miyazaki T (2014) Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PLoS One 9(8), e105370. doi:10.1371/journal.pone.0105370. eCollection
Sato M, Uzu K, Yoshida T, Hamad EM, Kawakami H, Matsuyama H, Abd El-Gawad IA, Imaizumi K (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99:1013–1017
Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669–682
Shiozaki T, Iwai A, Kawaoka Y, Takada A, Kida H, Miyazaki T (2011) Requirement for Siva-1 for replication of influenza A virus through apoptosis induction. J Gen Virol 92(Pt 2):315–325. doi:10.1099/vir.0.028316-0
Takeda S, Iwai A, Nakashima M, Fujikura D, Chiba S, Li HM, Uehara J, Kawaguchi S, Kaya M, Nagoya S, Wada T, Yuan J, Rayter S, Ashworth A, Reed JC, Yamashita T, Uede T, Miyazaki T (2007) LKB1 is crucial for TRAIL-mediated apoptosis induction in osteosarcoma. Anticancer Res 27(2):761–768
Taubenberger JK, Morens DM (2010) Influenza: the once and future pandemic. Public Health Rep 125(Suppl 3):16–26
Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:1109–1113
Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727–740
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Miyazaki, T. (2015). Efficacy of Probiotics in Prevention of Influenza. In: Liong, MT. (eds) Beneficial Microorganisms in Medical and Health Applications. Microbiology Monographs, vol 28. Springer, Cham. https://doi.org/10.1007/978-3-319-23213-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-23213-3_6
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23212-6
Online ISBN: 978-3-319-23213-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)